# Determination of the Predictive Factors in the Reversibility or the Aggravation in the Disorders of the Glucose Metabolism in Cystic Fibrosis Patients

> **NCT01072708** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 230 (actual)

## Conditions studied

- Diabetes in Cystic Fibrosis Patients

## Interventions

- **OTHER:** Prospective cohort with an annual follow-up

## Key facts

- **NCT ID:** NCT01072708
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072708, "Determination of the Predictive Factors in the Reversibility or the Aggravation in the Disorders of the Glucose Metabolism in Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01072708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*